Bahriye Payzın

643 total citations
33 papers, 450 citations indexed

About

Bahriye Payzın is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, Bahriye Payzın has authored 33 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 11 papers in Hematology and 8 papers in Genetics. Recurrent topics in Bahriye Payzın's work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Viral-associated cancers and disorders (5 papers). Bahriye Payzın is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Viral-associated cancers and disorders (5 papers). Bahriye Payzın collaborates with scholars based in Türkiye, United States and United Kingdom. Bahriye Payzın's co-authors include Zeliha Hekimsoy, İnci Alacacıoğlu, Işıl Somali, Alper Can, Çiğdem Erten, Ahmet Dirican, Yüksel Küçükzeybek, İbrahim Vedat Bayoğlu, Lütfiye Demir and Aylin Örgen Çallı and has published in prestigious journals such as SHILAP Revista de lepidopterología, Acta Oncologica and Journal of Diabetes and its Complications.

In The Last Decade

Bahriye Payzın

31 papers receiving 422 citations

Peers

Bahriye Payzın

ONCOL

CCM

EDM

PRM

EPIDE

Kara Thompson United States

Dana E. Angelini United States

Eyüp Büyükkaya Türkiye

Kamil Bujak Poland

Chadi Saifan United States

S. Tzila Zwas Israel

Thompson Cb United States

Selma Yazıcı Türkiye

J Fernández-Llamazares Spain

Jeffrey P. Lamont United States

Kara Thompson United States

Bahriye Payzın

203 ×0.8

ONCOL

222 ×1.9

CCM

42 ×0.5

EDM

134 ×1.6

PRM

41 ×0.6

EPIDE

Citations per year, relative to Bahriye Payzın Bahriye Payzın (= 1×) peers Kara Thompson

Countries citing papers authored by Bahriye Payzın

Since Specialization

Citations

This map shows the geographic impact of Bahriye Payzın's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bahriye Payzın with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bahriye Payzın more than expected).

Fields of papers citing papers by Bahriye Payzın

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bahriye Payzın. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bahriye Payzın. The network helps show where Bahriye Payzın may publish in the future.

Co-authorship network of co-authors of Bahriye Payzın

This figure shows the co-authorship network connecting the top 25 collaborators of Bahriye Payzın. A scholar is included among the top collaborators of Bahriye Payzın based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bahriye Payzın. Bahriye Payzın is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Çallı, Aylin Örgen, et al.. (2024). Prognostic significance of bone marrow fibrosis in diffuse large B‐cell lymphoma. International Journal of Laboratory Hematology. 46(3). 523–530. 1 indexed citations

Payzın, Bahriye, et al.. (2020). BCR-ABL1–Negative Chronic Myeloproliferative Neoplasms and Pulmonary Hypertension: A Prospective Long-Term Follow-up Study of the Impact of Pulmonary Hypertension on Survival. Clinical Lymphoma Myeloma & Leukemia. 21(2). 125–131. 3 indexed citations

Vural, Filiz, Güray Saydam, Fahri Şahin, et al.. (2019). Retrospective Analysis of Hairy Cell Leukemia Patients Treated with Different Modalities as First Line: Real-Life Experience Over 20 years. Indian Journal of Hematology and Blood Transfusion. 35(4). 692–698. 1 indexed citations

Çiftçiler, Rafiye, Ömür Gökmen Sevindik, Mehmet Ali Erkurt, et al.. (2019). Acute lymphoblastic leukemia in routine practice: A Turkish multicenter study. Turkish Journal of Hematology. 36(3). 169–177. 2 indexed citations

Yılmaz, Asu Fergün, et al.. (2019). Clinical Features and Treatment Outcomes of Warm Autoimmune Hemolytic Anemia: A Retrospective Analysis of 60 Turkish Patients. Indian Journal of Hematology and Blood Transfusion. 35(3). 523–530. 4 indexed citations

Yılmaz, Asu Fergün, et al.. (2017). Development of Hodgkin lymphoma in a patient with sarcoidosis. Reumatismo. 69(2). 84–84. 2 indexed citations

Payzın, Bahriye, et al.. (2015). Effectiveness of Quantitative Real Time PCR in Long-Term Follow-up of Chronic Myeloid Leukemia Patients.. PubMed. 25(8). 568–72. 1 indexed citations

Özcan, Mehmet Ali, et al.. (2015). The Effect of FcγRIIIA Gene Polymorphism on the Treatment of Diffuse Large B-cell Non-Hodgkin Lymphoma: A Multicenter Prospective Observational Study. SHILAP Revista de lepidopterología. 32(2). 152–157. 3 indexed citations

Alacacıoğlu, İnci, Güner Hayri Özsan, Bahriye Payzın, et al.. (2014). Is the BFM Regimen Feasible for the Treatment of Adult Acute Lymphoblastic Leukemia? A Retrospective Analysis of the Outcomes of BFM and Hyper-CVAD Chemotherapy in Two Centers. Chemotherapy. 60(4). 219–223. 23 indexed citations

10.

Payzın, Bahriye, et al.. (2014). JAK2 V617F Mutation Status of 232 Patients Diagnosed With Chronic Myeloproliferative Neoplasms. Clinical Lymphoma Myeloma & Leukemia. 14(6). 525–533. 11 indexed citations

11.

Dirican, Ahmet, Yüksel Küçükzeybek, Çiğdem Erten, et al.. (2013). Prognostic and Predictive Value of Hematologic Parameters in Patients with Metastatic Renal Cell Carcinoma: Second Line Sunitinib Treatment Following IFN-alpha. Asian Pacific Journal of Cancer Prevention. 14(3). 2101–2105. 26 indexed citations

12.

Ci̇ri̇t, Mustafa, et al.. (2012). The Value of Serum Immunoglobulin Free Light Chain Assessment in Patients with Monoclonal Gammopathies and Acute Renal Failure. SHILAP Revista de lepidopterología. 29(4). 385–391. 1 indexed citations

13.

Rezanko, Türkan, et al.. (2012). Lymphoma of the cervix: A diagnostic pitfall on cervicovaginal smear. Journal of Cytology. 29(3). 213–213. 12 indexed citations

14.

Payzın, Bahriye, et al.. (2009). Kraniofasiyal Mukormikoz: Bir Olgu Sunumu. DergiPark (Istanbul University). 14(3). 210–212. 1 indexed citations

15.

Kebapçılar, Levent, Oktay Bilgir, İnci Alacacıoğlu, et al.. (2009). Does Imatinib Mesylate Therapy Cause Growth Hormone Deficiency?. Medical Principles and Practice. 18(5). 360–363. 15 indexed citations

16.

Payzın, Bahriye, et al.. (2006). Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease.. PubMed. 17(3). 183–90. 7 indexed citations

17.

Hekimsoy, Zeliha, et al.. (2004). Mean platelet volume in Type 2 diabetic patients. Journal of Diabetes and its Complications. 18(3). 173–176. 255 indexed citations

18.

Ekinci, Neşe, et al.. (2001). Extramedullary Plasmacytoma of the Parotid Gland. Acta Cytologica. 45(3). 449–453. 11 indexed citations

19.

Payzın, Bahriye, et al.. (1995). Paraneoplastic Cerebellar Degeneration in Association with Hodgkin’s Disease: A Report of Two Cases. Acta Haematologica. 94(4). 210–213. 6 indexed citations

20.

Çavdar, Caner, et al.. (1994). Oncogenous Osteomalacia-Report of a Case. Acta Oncologica. 33(8). 975–976. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact